Canadian Task Force (CTF) - Summary Table of "D" Recommendations

Summary Table of "D" Recommendations
Fair Evidence to Exclude from PHE (DON'T)

CONDITION MANEUVER POPULATION

Bladder cancer Urine dipstick or cytology General population

Breast cancer Tamoxifen to reduce the risk of breast cancer Low-risk women

Breast cancer Teach breast self-examination Women aged 40-49 and women aged 50-59

Cardiovascular and cerebrovascular disease Hormone replacement therapy Postmenopausal women

Carotid disease/ Stroke Neck auscultation or carotid endarterectomy General population

Cervical cancer Human papillomavirus screening Women

Child maltreatment Screen for risk of maltreating children General population

Child maltreatment Approaches to identify families at high risk Families with children

Chlamydial infection Smear, culture or analysis General population

Chronic diseases Hormone replacement therapy Menopausal women

Colorectal cancer Fecal occult blood testing or sigmoidoscopy Those with cancer family syndrome

Cystic fibrosis DNA analysis for carrier status General population

Cystic fibrosis Sweat test, immunoreactive trypsin and "BM meconium" test General population

Depression General Health Questionnaire or Zung Self-rating depression scale General population

Developmental Hip Dysplasia Ultrasound screening Normal-risk infants

Developmental Hip Dysplasia Selective screening High-risk infants and infants with family history of DDH

Developmental Hip Dysplasia Radiographic
examination of hips
and pelvis High-risk infants (aged 3 - 5 months)

Developmental problems Denver Developmental Scale Preschool children

Diabetes mellitus Blood glucose, fasting Non-pregnant general population

Gonorrhea Gram stain/culture of cervical or urethral smear General population

Hearing problems History, clinical examination Preschool children

Low birth weight/Preterm birth Programs of only social support High risk pregnant women

Lung cancer Chest radiography General population

Neonatal morbidity and mortality Electronic fetal monitoring, intrapartum Low risk pregnancies

Obesity Low calorie diet Pre-adolescent obese children

Oral cancer mortality Population screening by clinical examination General population

Osteoporotic fractures Bone mineral density screening Women

Ovarian cancer Pelvic exam, transvaginal ultrasound, CA 125 or combination Pre- and Post-menopausal Women

Pancreatic cancer Abdominal palpation, ultrasound or serologic tumor markers General population

Periodontal disease Brushing with electric toothbrush General population

Pneumococcal pneumonia Immunization, one dose Immunocompromised patients

Preterm birth Home uterine activity monitoring Low risk pregnancies

Progressive renal disease Urine dipstick General population

Prostate cancer Prostate specific antigen Males >50 years

Prostate cancer Transrectal ultrasound Males >50 years

Recurrent herpes simplex type II (progenitalis) infection Cervical smear, culture; weekly screening Pregnant women with history, active disease, or partner with proven infection

Stroke Echocardiography: Transthoracic (TTE) or transesophageal (TEE) for detection of intracardiac masses Patients with pre-existing indications for anticoagulation or contraindications to anticoagulation

Testicular cancer Tumour markers Adolescent and adult males

Urinary infection Urine dipstick Newborns and infants

Urinary infection Urine dipstick or culture Elderly, ambulatory men

Back to Summary Tables of Current Recommendations

CTFPHC Home Page

CONDITION	MANEUVER	POPULATION
Bladder cancer	Urine dipstick or cytology	General population
Breast cancer	Tamoxifen to reduce the risk of breast cancer	Low-risk women
Breast cancer	Teach breast self-examination	Women aged 40-49 and women aged 50-59
Cardiovascular and cerebrovascular disease	Hormone replacement therapy	Postmenopausal women
Carotid disease/ Stroke	Neck auscultation or carotid endarterectomy	General population
Cervical cancer	Human papillomavirus screening	Women
Child maltreatment	Screen for risk of maltreating children	General population
Child maltreatment	Approaches to identify families at high risk	Families with children
Chlamydial infection	Smear, culture or analysis	General population
Chronic diseases	Hormone replacement therapy	Menopausal women
Colorectal cancer	Fecal occult blood testing or sigmoidoscopy	Those with cancer family syndrome
Cystic fibrosis	DNA analysis for carrier status	General population
Cystic fibrosis	Sweat test, immunoreactive trypsin and "BM meconium" test	General population
Depression	General Health Questionnaire or Zung Self-rating depression scale	General population
Developmental Hip Dysplasia	Ultrasound screening	Normal-risk infants
Developmental Hip Dysplasia	Selective screening	High-risk infants and infants with family history of DDH
Developmental Hip Dysplasia	Radiographic examination of hips and pelvis	High-risk infants (aged 3 - 5 months)
Developmental problems	Denver Developmental Scale	Preschool children
Diabetes mellitus	Blood glucose, fasting	Non-pregnant general population
Gonorrhea	Gram stain/culture of cervical or urethral smear	General population
Hearing problems	History, clinical examination	Preschool children
Low birth weight/Preterm birth	Programs of only social support	High risk pregnant women
Lung cancer	Chest radiography	General population
Neonatal morbidity and mortality	Electronic fetal monitoring, intrapartum	Low risk pregnancies
Obesity	Low calorie diet	Pre-adolescent obese children
Oral cancer mortality	Population screening by clinical examination	General population
Osteoporotic fractures	Bone mineral density screening	Women
Ovarian cancer	Pelvic exam, transvaginal ultrasound, CA 125 or combination	Pre- and Post-menopausal Women
Pancreatic cancer	Abdominal palpation, ultrasound or serologic tumor markers	General population
Periodontal disease	Brushing with electric toothbrush	General population
Pneumococcal pneumonia	Immunization, one dose	Immunocompromised patients
Preterm birth	Home uterine activity monitoring	Low risk pregnancies
Progressive renal disease	Urine dipstick	General population
Prostate cancer	Prostate specific antigen	Males >50 years
Prostate cancer	Transrectal ultrasound	Males >50 years
Recurrent herpes simplex type II (progenitalis) infection	Cervical smear, culture; weekly screening	Pregnant women with history, active disease, or partner with proven infection
Stroke	Echocardiography: Transthoracic (TTE) or transesophageal (TEE) for detection of intracardiac masses	Patients with pre-existing indications for anticoagulation or contraindications to anticoagulation
Testicular cancer	Tumour markers	Adolescent and adult males
Urinary infection	Urine dipstick	Newborns and infants
Urinary infection	Urine dipstick or culture	Elderly, ambulatory men